Treace Medical Concepts Inc. (TMCI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
100 PALMETTO PARK PLACE PONTE VEDRA, FL 32081 |
| State of Incorp. | FL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 75,677 | 123,198 | 81,252 | 105,833 | |||
| Cash and cash equivalent | 11,350 | 12,982 | 19,473 | 105,833 | |||
| Short-term investments | 64,327 | 110,216 | 61,779 | ||||
| Receivables | 40,803 | 38,063 | 29,196 | 18,568 | |||
| Inventory, net of allowances, customer advances and progress billings | 39,255 | 29,245 | 19,330 | 10,561 | |||
| Inventory | 39,255 | 29,245 | 19,330 | 10,561 | |||
| Other undisclosed current assets | 5,667 | 7,853 | 3,624 | 3,010 | |||
| Total current assets: | 161,402 | 198,359 | 133,402 | 137,972 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 8,442 | 9,264 | 10,138 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 25,953 | 22,298 | 15,338 | 2,849 | |||
| Intangible asset, including goodwill, after accumulated amortization | 20,890 | 21,840 | |||||
| Goodwill | 12,815 | 12,815 | |||||
| Intangible asset, excluding goodwill, after accumulated amortization | 8,075 | 9,025 | |||||
| Other noncurrent assets | 407 | 146 | 146 | ||||
| Other receivable, after allowance for credit loss | ✕ | ✕ | |||||
| Other undisclosed noncurrent assets | |||||||
| Total noncurrent assets: | 55,692 | 53,548 | 25,622 | 2,849 | |||
| TOTAL ASSETS: | 217,094 | 251,907 | 159,024 | 140,821 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 17,719 | 22,293 | 14,884 | 13,029 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 4,455 | ||
| Accounts payable | 10,522 | 11,835 | 8,668 | 4,056 | |||
| Accrued liabilities | 7,197 | 10,458 | 6,216 | 4,518 | |||
| Debt | |||||||
| Other undisclosed current liabilities | 17,206 | 22,740 | 15,361 | 5,181 | |||
| Total current liabilities: | 34,925 | 45,033 | 30,245 | 18,210 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 53,306 | 53,008 | 52,711 | 29,365 | |||
| Long-term debt, excluding current maturities | 53,306 | 53,008 | 52,711 | 29,365 | |||
| Liabilities, other than long-term debt | 15,971 | 15,928 | 15,539 | 173 | |||
| Other liabilities | 37 | 37 | |||||
| Operating lease, liability | 15,934 | 15,891 | 15,539 | ||||
| Derivative instruments and hedges, liabilities | 173 | ||||||
| Total noncurrent liabilities: | 69,277 | 68,936 | 68,250 | 29,538 | |||
| Total liabilities: | 104,202 | 113,969 | 98,495 | 47,748 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 112,892 | 137,938 | 60,529 | 93,073 | |||
| Common stock | 62 | 62 | 55 | ||||
| Treasury stock, value | (281) | (13) | |||||
| Additional paid in capital | 303,004 | 271,973 | 145,221 | 134,933 | |||
| Accumulated other comprehensive income (loss) | 97 | 163 | (27) | ||||
| Accumulated deficit | (189,990) | (134,247) | (84,720) | (41,905) | |||
| Other undisclosed equity, attributable to parent | 45 | ||||||
| Total equity: | 112,892 | 137,938 | 60,529 | 93,073 | |||
| TOTAL LIABILITIES AND EQUITY: | 217,094 | 251,907 | 159,024 | 140,821 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Revenues | 209,357 | 187,118 | 141,838 | 94,419 | ||
| Cost of revenue (Cost of Product and Service Sold) | (41,093) | (35,181) | (27,523) | (17,826) | ||
| Gross profit: | 168,264 | 151,937 | 114,315 | 76,593 | ||
| Operating expenses | (223,952) | (203,365) | (149,159) | (93,103) | ||
| Operating loss: | (55,688) | (51,428) | (34,844) | (16,510) | ||
| Nonoperating income (expense) | (55) | 2,201 | (7,971) | (4,024) | ||
| Other nonoperating income (expense) | (55) | 1,901 | (7,971) | (4,042) | ||
| Interest and debt expense | (5,167) | (4,483) | (4,060) | |||
| Loss from continuing operations: | (55,743) | (54,394) | (47,298) | (24,594) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (24,594) | |
| Other undisclosed net income | 4,867 | 4,483 | 4,042 | |||
| Net loss attributable to parent: | (55,743) | (49,527) | (42,815) | (20,552) | ||
| Preferred stock dividends and other adjustments | (196) | |||||
| Net loss available to common stockholders, diluted: | (55,743) | (49,527) | (42,815) | (20,748) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Net loss: | (55,743) | (49,527) | (42,815) | (20,552) | ||
| Comprehensive loss: | (55,743) | (49,527) | (42,815) | (20,552) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (66) | 190 | (27) | |||
| Comprehensive loss, net of tax, attributable to parent: | (55,809) | (49,337) | (42,842) | (20,552) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.